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Abstract
Although an increased expression level of XIAP is associated with cancer cell metastasis, the underlying molecular
mechanisms remain largely unexplored. To verify the specific structural basis of XIAP for regulation of cancer cell migration,
we introduced different XIAP domains into XIAP
2/2 HCT116 cells, and found that reconstitutive expression of full length
HA-XIAP and HA-XIAP DBIR, both of which have intact RING domain, restored b-Actin expression, actin polymerization and
cancer cell motility. Whereas introduction of HA-XIAP DRING or H467A mutant, which abolished its E3 ligase function, did
not show obvious restoration, demonstrating that E3 ligase activity of XIAP RING domain played a crucial role of XIAP in
regulation of cancer cell motility. Moreover, RING domain rather than BIR domain was required for interaction with RhoGDI
independent on its E3 ligase activity. To sum up, our present studies found that role of XIAP in regulating cellular motility
was uncoupled from its caspase-inhibitory properties, but related to physical interaction between RhoGDI and its RING
domain. Although E3 ligase activity of RING domain contributed to cell migration, it was not involved in RhoGDI binding nor
its ubiquitinational modification.
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Introduction
The X-linked inhibitor of apoptosis protein (XIAP) is a member
of the inhibitors of the apoptosis protein (IAP) family [1]. XIAP
was first recognized by its potent properties in regulating cell
apoptosis [2,3]. Later investigations found that XIAP may regulate
other cellular pathways uncoupled from its caspase-inhibitory
activities [4,5], majorly inspired by the findings from XIAP-
deficient mice which displayed no overt apoptotic phenotype [6].
Recently a wide variety of evidence has suggested that the
involvements of XIAP in copper metabolism [7], cell motility [8,9]
and activation of JNK and NFkB pathways [10,11] were unrelated
to its inhibitory effect on caspases.
The multiple functions of XIAP root from its structural basis.
XIAP is composed of three baculoviral IAP repeat (BIR) domains
at amino-terminus and one carboxyl-terminal RING domain [12].
Each BIR domain consists of approximately 70 amino acids that
coordinate a zinc ion via histidine and cystein residues [13]. Its
potent anti-apoptotic properties are mainly dependent on the
functions of a groove in the BIR3 domain and two surfaces on the
BIR2 domain which have been reported to bind and inhibit
caspase-9 and caspase-3/7 respectively [14]. RING domain is
defined by the presence of seven cysteins and one histidine that
form cross brace architecture and coordinate two zinc ions [15].
RING domains often function as modulates that confer ubiquitin
ligase (E3) activity [13]. By mutating the key histidine residue at
amino acid 467 to alanine of human XIAP, Lewis et al found that
E3 ubiquitin ligase function of RING was required for the
activation of NFkB, while not for Smad-dependent transcription
[16], indicating that structure-based functions of XIAP are also
cellular context dependent.
Increased expression of XIAP is found in many cancer tissues
and associated with chemoresistance, disease progression and poor
prognosis [9,17,18,19,20,21,22]. The recent findings from our
laboratory and others’ demonstrated that XIAP could regulate
tumor metastasis [8,23,24]. Tumor metastasis is a major cause of
death for most cancer patients [25]. Many molecules involved in
metastatic cascade are controlled by the members of Ras-
superfamily of small GTP-binding proteins, which are able to
bind GDP/GTP and hydrolyze GTP leading to activation of
downstream effector proteins [26]. Human Rho-GTPase subfam-
ily comprises 23 signaling molecules, among which RhoA, RhoB,
Rac1 and Cdc42 are most extensively investigated and reported to
control various aspects of cellular motility and invasion, i.e.,
cellular polarity, ctyoskeletal organization, and signal transduction
[27,28].
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nents involved in GDP/GTP-bound GTPase cycle, including
GTPase-activating proteins (GAPs), GDP-dissociation inhibitors
(GDIs), GDI dissociation factors (GDFs), and guanine nucleotide
exchange factors (GEFs) [29]. RhoGDI plays a key role in
balancing the entire GTPase cycle by preventing GDP dissocation
and maintaining GTP association through interaction with the
prenylation group of GTPase. Thus, it sequesters GTPase in the
cytoplasm while localization to the inner plasma membrane is
necessary for GTPase activation. The inhibitory effects of
RhoGDI on GTPase activity have been supported by several
lines of evidence [30,31,32]. For instance, Leffers et al. have found
that overexpression of RhoGDI in human keratinocytes caused
disruption of actin cytoskeleton and inhibition of motility [32].
Therefore, RhoGDI is regarded as an attractive candidate for
regulating the activity of Rho GTPase in cancer treatment [26].
Our recent studies have proven that XIAP mediated cancer cell
motilities via RhoGDI-dependent manner in regulation of
cytoskeleton [23]. In the current study, we further elucidated the
molecular mechanisms underlying XIAP-RhoGDI protein inter-
action and provided the structural basis of XIAP for the
contribution to mediation of cancer cell motility.
Results
RING domain was required for XIAP-mediated b-Actin
expression
XIAP expression is elevated in many cancer cell lines and
closely related to the progression and aggression of malignant
cancer [33,34]. Our recent work demonstrated that XIAP could
regulate b-Actin expression [23]. As a result, depletion of XIAP
expression attenuated cell migration rate and invasive capability as
shown in wound healing assay and trans-well assay, respectively
(Figs. 1A–1E). To note, there was only marginal difference in
proliferation rate between WT and XIAP
2/2 cells when cultured
in normal cell culture medium (10% FBS) for up to 5 days, which
included the time range for wound healing assay (Fig. 1F),
indicating that the reduced cell migration rate observed in
XIAP
2/2 cells was not due to defective cell proliferation.
Moreover, the dynamic induction of actin polymerization, namely
F-Actin formation, by EGF was also dramatically reduced in
XIAP
2/2 cells detected by spectrophotometer (Fig. 1G). Consis-
tently, a clear change of cell skeleton morphology and more
peripheral ruffles/membrane ruffles were observed in EGF-treated
WT HCT116 cells but not in XIAP
2/2 cells (Figs. 1H & 1I).
These phenomena were reproducible by knocking down XIAP in
HCT116 cells (Fig. 2). Therefore it indicated that XIAP played a
key role in mediation of cancer cell migration and invasion.
XIAP protein contains four functional domains, including three
BIRs and a RING domain (Fig. 3A). The anti-apoptotic function
of XIAP BIRs was reported to be attributable to their binding and
impairment of caspase activation [1]. The RING domain of XIAP
belongs to E3 ligase and mediates protein ubiquitination and
degradation [1]. To verify the specific structural basis of XIAP for
regulation of cancer cell migration, we transfected different HA-
tagged XIAP cDNA constructs, including full-length (HA-XIAP),
RING domain-deletion (HA-XIAPDRING), total BIR deletion
(HA-XIAPDBIR), and a point mutation H467A, which results in
loss of E3 ubiquitin ligase activity, into XIAP
2/2 cells respectively,
and the stable transfectants were identified (Fig. 3B). Re-
constitutional expression of HA-XIAP or HA-XIAP DBIR that
contains RING domain into XIAP
2/2 cells resulted in an increase
in b-Actin expression as compared to that in XIAP
2/2 (Vector)
cells, while expression of HA-XIAP DRING that contains BIR
domains, or HA-XIAP H467A that renders abolishment in E3
ligase activity, did not provide comparable restoration (Fig. 3C).
Therefore, it demonstrated that XIAP RING domain and its E3
ligase activity played a role in regulation of b-Actin expression.
E3 ligase activity of XIAP RING domain was involved in
mediation of cell migration and actin polymerization
To further explore the biological relevance of b-Actin
expression change regulated by XIAP RING domain, wound
healing assay was performed to compare the migration rates
among various transfectants carrying different domains of XIAP as
identified in Fig. 3B. In accordance with defects in b-Actin
expression, introduction of neither HA-XIAP DRING nor HA-
XIAP H467A could reverse the impairment in cell migration of
XIAP
2/2 cells, while expression of full length HA-XIAP or HA-
XIAPDBIR, both of which hold intact RING domain, restored the
reduction of cell migration capability caused by XIAP depletion
(Fig. 4A). While due to the relative low expression of HA-
XIAPDBIR in comparison to that of HA-XIAP in the individual
transfectants (Fig. 3B), the wound healing rate observed in HA-
XIAPDBIR-expressing transfectants was slower than that in HA-
XIAP-expressing cells (Fig. 4A). The percentage of wound area left
un-closed on 4
th day compared with that on 0 day was quantified
using Cell Migration Analysis software, which showed that the
wound areas in XIAP
2/2(vector), HA-XIAP DRING and HA-
XIAP H467A transfectants were markedly higher than that in WT
HCT116 cells (Fig. 4B). Therefore, it suggested that E3 ligase
activity of RING domain played an important role in XIAP-
mediated cell motility.
Actin filaments play a central role in numerous cellular
functions, such as cell migration and morphological regulation
[35]. To determine potential involvement of different domains of
XIAP in regulation of actin polymerization, we treated cells with
EGF, and then extracted cells for determination of F-actin levels
by flow cytometry using the stable transfectants mentioned above.
Again, F-actin formations induced by EGF treatment were
obviously obtained in WT HCT116 cells, XIAP
2/2(HA-XIAP)
and XIAP
2/2(HA-XIAP DBIR) transfectants, whereas there was
no observable F-actin induction in XIAP
2/2(vector), XIAP
2/2
(HA-XIAP DRING) or XIAP
2/2(HA-XIAP H467A) transfectants
(Fig. 5A). The quantification result was shown in Fig. 5B. Taken
together, our results demonstrated that function of XIAP RING
domain in regulation of actin polymerization and cell motility was
mediated by its E3 ligase activity.
XIAP RING Domain interacted with RhoGDI, independent
on its E3 ligase activity
Our recent work demonstrated that RhoGDI was involved in
actin polymerization regulated by XIAP [23]. Therefore we
detected the physical interaction between these two molecules by
co-immunoprecipitation utilizing anti-XIAP specific antibody.
The results showed that RhoGDI was detected in the co-
immunoprecipitated complex in XIAP
+/+, but not XIAP
2/2
HCT116 cells (Fig. 6A), suggesting that RhoGDI might interact
with endogenous XIAP. The interaction between XIAP and
RhoGDI was further verified reciprocally by detection of XIAP in
co-immunoprecipitation complex pulled-down by anti-GFP anti-
body using transfectants of XIAP
2/2(HA-XIAP/GFP-RhoGDI),
whereas there was no detectable level of XIAP in Co-IP complex
in transfectants of XIAP
2/2 (HA-XIAP/GFP-vector) (Fig. 6B).
Then we knocked down RhoGDI in WT and XIAP
2/2 cells to
confirm the participation of RhoGDI in cell motility. Wound
healing assay results showed that knockdown of RhoGDI in WT
XIAP E3 Ligase and RhoGDI
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however a remarkably increased cell migration was observed in
XIAP
2/2(shRNA-RhoGDI) cells in comparison to that in non-
silencing control, XIAP
2/2(Non-silencing) cells (Fig. 6C). Consis-
tently, knockdown of RhoGDI expression also increased F-actin
content in XIAP
2/2(Si-RhoGDI) cells exposed to EGF (Fig. 6D,
p,0.05). The sequences of the RhoGDI gene (401–419), that was
complementary to siRNA oligonucleotide in pEGFP-C3/
RhoGDI-re construct, were mutated to prevent destruction of
exogenous mRNA by RhoGDI siRNA [36]. As shown in Fig. 6E,
overexpression of pEGFP-C3/RhoGDI-re was identified in
XIAP
2/2(Si-RhoGDI+RhoGDI-re). This reconstitutive expres-
sion of RhoGDI in XIAP
2/2(Si-RhoGDI+RhoGDI-re) dramat-
ically attenuated actin polymerization induced by EGF treatment
in comparison to that in XIAP
2/2(Si-RhoGDI) cells (2% vs. 14%,
p,0.01, Fig. 6F). Moreover, reconstitutive expression of RhoGDI
in XIAP
2/2(Si-RhoGDI+RhoGDI-re) cells restored inhibitory
role of RhoGDI on filamentous actin formation (Fig. 6G),
suggesting that reintroduction of RhoGDI-re enabled compensa-
tion for loss of endogenous RhoGDI function on actin polymer-
ization in XIAP
2/2 cells. Our results provided evidence that
RhoGDI might be involved in XIAP RING domain-mediated
regulation of actin polymerization and cell migration.
To determine specific XIAP domains involved in interaction
with RhoGDI protein, we co-transfected GFP-RhoGDI construct
with HA-XIAP, HA-XIAP H467A, HA-XIAP DRING and HA-
XIAP DBIR respectively, into XIAP
2/2 cells. As shown in Fig. 7A,
HA-tag was detected in the co-immunocomplex pulled down by
anti-GFP antibody in transfectants harboring HA-XIAP and HA-
XIAP DBIR. Moreover, similar affinity to GFP-RhoGDI was
observed in transfectants of HA-XIAP H467A, a mutation with
loss of E3 ligase activity in RING domain. While only a marginal
band of HA was observed in the immunocomplex from HA-XIAP
DRING transfectants, revealing that XIAP RING domain played
Figure 1. XIAP promoted HCT116 cell migration and invasion. (A), Knockout of XIAP in HCT116 cells was verified by Western Blotting assay. (B
and C), Cell migration behavior was evaluated during performance of a wound-healing assay, and images were taken at different time points. Scale
bar was 300 mm. The wound area was quantified using Cell Migration Analysis software, and the quantitative data were shown as indicated (error bar
represent S.D, n=3). The asterisk (*) indicates a significant difference in wound area percentage between the indicated cell lines (p,0.05). (D and E),
Invasion of WT(Vector), XIAP
2/2(Vector), and XIAP
2/2(HA-XIAP) HCT116 cells was determined, quantified and expressed as percentage of invasion.
Results were represented by the mean 6 S.D. of the data from three-independent experiments with duplicate wells for each experiment. The asterisk
(*) indicates a significant decrease in invasion percentage compared with that in WT(vector) and XIAP
2/2(HA-XIAP) cells (p,0.01). (F), The proliferate
rates of the indicated cell lines were assessed by a CellTiter-GloH Luminescent Cell Viability Assay kit. Results were represented by the mean 6 S.D. of
the triplicate wells. (G–I), The indicated cells were treated with or without EGF and F-actin induction was analyzed by spectrophotometer (G), or
observed under confocal microscope (H), respectively. The fluorescence of cells was quantified by the software of ImageJ (I). The quantitative data
was shown as indicated (error bar represent S.D, n=3). The asterisk (*) indicates a significant decrease compared with that in WT cells (p,0.01).
doi:10.1371/journal.pone.0035682.g001
Figure 2. The requirement of XIAP for cell motility was confirmed by knocking down approach. (A), Knockdown of XIAP in HCT116 cells
were verified by Western Blotting assay. (B and C), Cell migration behavior was evaluated during performance of a wound-healing assay, and images
were taken at different time points. Scale bar was 300 mm. The wound area was quantified using Cell Migration Analysis software, and the
quantitative data were shown as indicated (error bar represent S.D, n=3). The asterisk (*) indicates a significant difference in wound area percentage
between the indicated cell lines (p,0.05).
doi:10.1371/journal.pone.0035682.g002
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activity. In addition, although RING domain of XIAP could bind
to RhoGDI, their interaction did not result in ubiquitination of
RhoGDI (Figs. 7B and 7C). Conjugation of ubiquitin to RhoGDI
was barely detected even in the presence of exogenous wild type
ubiquitin in the immunocomplex pulled down by GFP which was
tagged to RhoGDI (Fig. 7B). Neither did expressing mutant of
ubiquitin render any obvious reductions in ubiquitination of
RhoGDI (Fig. 7B). Also there was no observable difference in
RhoGDI ubiquitination among WT cells and XIAP
2/2 cells
(Fig. 7B). The similar findings were reproduced in 293T cells as
shown in Fig. 7C. Therefore, it was suggested that although E3
ligase activity was required for XIAP-mediated cell migration, it
was not essential for RhoGDI binding, neither for its ubiquitina-
tional modification.
Discussion
Our previous findings have demonstrated that either knockout
or knockdown of XIAP decreased HCT116 cell migration and
invasion [23]. In the present study, we provided the structural
basis of XIAP for its regulatory functions in cancer metastasis. By
introducing different XIAP domains into XIAP
2/2 cells, our work
showed that RING domain rather than BIR domain was required
for b-Actin expression, cell migration as well as RhoGDI
interaction. E3 ligase activity of RING domain contributed to
the first two effects, but was not involved in RhoGDI binding nor
its ubiquitinational modification, indicating that role of XIAP in
regulating cellular motility was uncoupled from its caspase-
inhibitory properties, but related to its RING function which
was partly attributable to physical interaction with RhoGDI
(Fig. 7D).
In wound healing assay, we found that reconstitutive expression
of full length HA-XIAP and HA-XIAP DBIR, both of which have
RING domain, into XIAP
2/2 HCT116 cells restored cancer cell
motility, whereas introduction of HA-XIAP DRING or H467A
mutant, which abolished its E3 ligase function, did not show
obvious restoration, demonstrating that E3 ligase activity of XIAP
RING domain played a role in XIAP regulation of cancer cell
motility. Alterations in b-Actin levels aroused by expressing
various domains of XIAP were consistent with their effects in cell
migration. The chief intracellular ‘‘motor’’ of cell migration is
actin cytoskeleton [37]. Previous studies suggested that EGF
induced cell migration by reorganization of actin cytoskeleton and
massive accumulation of F-actin [38]. In our studies, malfunction
of actin polymerization in XIAP
2/2 cells could be rescued by re-
constitutional expression of either full length HA-XIAP or HA-
XIAP DBIR, while overexpression of HA-XIAP DRING or
H467A showed none of those restorations. In agreement of our
findings, Mehrotra’s unpublished data also acclaimed that E3
ligase activity of XIAP was critical for its regulatory role in cell
metastasis based on the observation that H467A XIAP mutant
failed to synergize with survivin in stimulating NFkB-dependent
pathway [24]. Therefore, it was clear that function of XIAP in
regulation of cell migration was dependent on its E3 ligase activity
of RING domain rather than related with its anti-apoptotic
potentials.
It has been suggested that role of IAPs in cell motility may be
evolutionary conserved since the Drosophila IAP homolog DIAP1
has been implicated in cell migration and morphogenesis by
controlling non-apoptotic caspase activity [13]. DIAP1 has been
shown to promote follicle cells migration within the egg chamber
during Drosophila oogenesis via regulating activity of small GTPase,
Figure 3. Various XIAP domains were reconstitutivly expressed into XIAP
2/2 cells. (A), Schematic representation of XIAP protein and
identified function of each domain. (B and C), Identification of the stable transfectants harboring XIAP and its various deletion plasmids in XIAP
2/2
HCT116 cells. The numbers under the bands indicated the densitometric analysis of relative ratios of b-Actin levels to loading controls (GAPDH)
evaluated by software of ImageQuant Version 5.2 (Molecular Dynamics, Sunnyvale, CA). Results were representative of at least three independent
experiments.
doi:10.1371/journal.pone.0035682.g003
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probably due to alterations in actin-dependent cellular organiza-
tion [13], which was quite similar with what we observed in
XIAP
2/2 cells in the current studies. Small GTPases play
important functions in a plethora of cellular events, such as
regulating filamentous actin systems [39]. Rho family GTPases act
as molecular switches cycling between inactive GDP-bound form
in cytosol and active GTP-bound state in cytoplasm membrane
[40]. RhoGDI was characterized as a down-regulator of Rho
GTPases by extracting them from membranes and solubilizing
them in the cytosol. RhoGDI also can interact with the switch
regions of GTPases and restrict the accessibility to GEFs and
GAPs so as to keep GTPase in the inactive states [39]. As we
reported here, XIAP was able to physically interact with RhoGDI
and inhibit its activity in regulation actin cytoskeleton assembly. So
when XIAP was highly expressed, RhoGDI activity was
suppressed which provided an explanation for the observations
that knocking down RhoGDI in WT HCT116 cells did not affect
wound closure rate since RhoGDI activity already has been
inhibited by XIAP, while in XIAP
2/2 cells where the repressive
effect on RhoGDI activity was invalidate, RhoGDI knocking
down exhibited much more obvious biological effects.
Figure 4. Different XIAP domains involved in cell migration disparately. (A), Cell migration behavior was evaluated with a wound-healing
assay, and images were taken at different time points. Scale bar was 300 mm. (B), The wound area left un-closed on the 4
th day was quantified using
Cell Migration Analysis software, and the quantitative data was shown as indicated (error bar represent S.D, n=2). The asterisk (*) indicates a
significant difference in percentage of wound area compared with that in WT (Vector) cells (p,0.05).
doi:10.1371/journal.pone.0035682.g004
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DBIR), but not BIR domains (XIAP DRING), could be co-
immunoprecipitated in the immune complex using the antibody
specific against GFP-RhoGDI. Although E3 ligase activity of
RING domain was shown to be required for cell migration,
impairment of its function by H467A mutation did not affect
interaction with RhoGDI. So it was hypothesized that besides
RhoGDI, there might be other downstream targets of E3 ligase
activity of XIAP responsible for controlling cell motility, like NFkB
[24] or some un-identified factors. Although E3 ligase activity of
XIAP contributed to autoubiquitination of XIAP itself and
ubiquitination of its binding partners, like Smac and AIF,
RhoGDI was not subjected to ubiquitin conjugation even when
XIAP was overexpressed.
Put together, our current studies revealed that E3 ligase activity
of XIAP RING domain contributed to actin polymerization,
cytoskeleton formation and cell migration. Although RING
domain was required for RhoGDI interaction which mediated
cell motilities, its E3 ligase activity was not involved in RhoGDI
binding or ubiqutination. The alternative molecular basis for its
E3 ligase activity still remains to be fully characterized.
Materials and Methods
Plasmids
Plasmids expressing HA-tagged XIAP, HA-XIAP DRING, HA-
XIAP DBIR, HA-XIAP H467A, and pEBB-HA expression empty
vector, were gifts from Dr. Colin S Duckett (University of Texas at
Austin, Austin, TX) [16]. pEGFP-C3/RhoGDI vector expressing
green fluorescent protein (GFP)-tagged RhoGDI and Rac1 was
kindly provided by Dr. Mark R. Philips (New York University
School of Medicine, New York, NY, USA). pRNA-U6/siRhoGDI
and pEGFP-C3/mRhoGDI (RhoGDI gene was mutated from
403-AAA GGC GTC AAG ATT GAC-420 to 403-AAG GGA
GTA AAA ATC GAT-420 to prevent destruction of exogenous
mRNA by the corresponding siRNA) was provided by Dr. BL
Zhang as described previously [36]. Human XIAP and RhoGDI
shRNA plasmids were purchased from Open Biosystems (Pitts-
burgh, PA).
Cell Culture and Transfection
Wild-type and XIAP
2/2 HCT116 cells (human colon cancer
cell lines) were kind gifts from Dr. Bert Vogelstein (Howard
Hughes Medical Institute and Sidney Kimmel Comprehensive
Cancer Center, The Johns Hopkins Medical Institutions, Balti-
more, MD) [37]. WT and XIAP
2/2 HCT116 cells were cultured
in McCoy’s 5A medium (Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum (FBS, Nova-Tech, Grand Island, NE)
and penicillin/streptomycin (Life Technologies, Grand Island,
NY). Cell transfections were performed with Lipofectamine
reagent (Invitrogen) or FuGENEH HD Transfection Reagent
(Roche Applied Science, Indianapolis, IN). For stable transfection,
cultures were subjected to hygromycin B or G418 or puromycin
(Life Technologies) drug selection, and cells surviving from the
antibiotic selection were pooled as stable mass transfectants. These
stable transfectants were then cultured in the selected antibiotic-
free medium for at least two passages before use in experiments.
Wound Healing Assay
Cells were seeded into each well of 6-well plates and cultured
until 80% confluence. Wounds were made by sterile pipette tips.
Cells were washed with serum-free PBS and then cultured in
normal medium for the various time points. Photos were taken
every 24 h until the wound was healed in the parental cells [41].
The wound area was quantified using the Cell Migration Analysis
software (Muscale LLC, Scottsdale, AZ).
Cell Invasion Assay
A BD BioCoatTM MatrigelTM Invasion Chamber (BD
Biosciences, San Diego, CA) was used for invasion assay. Cells
(2.5610
4) were seeded per insert in triplicate in 500 ml serum-free
McCoy’s 5A medium. Inserts were placed in wells containing
500 ml medium with 5% FBS and TPA (20 ng/ml). The cells were
incubated for 72 h in an incubator with 5% CO2 humidified
Figure 5. F-actin induction by EGF was regulated differently by various XIAP domains. (A), The indicated cells were treated with or
without EGF and F-Actin induction was analyzed by flow cytometry. (B), The quantitative data was shown as indicated (error bar represent S.D, n=2).
The asterisk (*) indicates a significant difference in F-actin induction compared with that in WT(Vector) cells (p,0.05).
doi:10.1371/journal.pone.0035682.g005
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pictured and then completely removed by wiping with a cotton
swab. The membrane was cut with a sharp scalpel and placed in
96-well plate. The levels of invaded/migrated cells were
determined by using CellTiter-GloH Luminescent Cell Viability
Assay kit (Promega, Madison, WI) with a luminometer (Wallac
1420 Victor2 multipliable counter system) as described previously
[42]. Invasion (%)=(ATP activity of invaded cells/ATP activity of
migrated cells)6100%.
Cell Proliferation Analysis
Viable cells (1610
3) suspended in 100 ml McCoy’s 5A medium
supplemented with 10% FBS were seeded into each well of 96-well
plates. The plates were incubated at 37uC in a humidified
atmosphere of 5% CO2. The cells were extracted with 50 ml lysis
buffer at various time points. Cell proliferation was measured by
using a CellTiter-GloH Luminescent Cell Viability Assay kit
(Promega). The results were expressed as relative proliferation
rate, which was calculated as following: relative proliferation
rate=ATP activity on the n
th day/ATP activity on 0 day.
Figure 6. RhoGDI was involved in XIAP regulation of cell migration and actin polymerization. (A), Lysates from WT and XIAP
2/2 HCT116
cells were Co-immunoprecipitated with anti-XIAP (mouse) antibody or normal mouse IgG, and immunoprecipitates were then subjected to
immunoblotting with anti-RhoGDI (rabbit) or anti-XIAP (rabbit) antibodies. Five percent of lysates was used as input. (B), XIAP
2/2(HA-XIAP) cells were
transiently transfected with the GFP-RhoGDI or empty vector, GFTP-Vector. Co-immunoprecipitation was performed with anti-GFP antibody-
conjugated agarose beads. Immunoprecipitates were then subjected to immunoblotting using antibodies as indicated. (C). Stable transfectants of
shRNA-RhoGDI in WT and XIAP
2/2 cells were identified. Cell migration was determined by wound healing assays at the indicated times between
Non-silencing and shRNA-RhoGDI transfectants in WT and XIAP
2/2 cells respectively. The wound area was quantified using Cell Migration Analysis
software, and the quantitative data was shown as indicated (error bar represent S.D, n=3). The asterisk (*) indicates a significant difference between
the indicated cell lines (p,0.05). Scale bar was 300 mm. (D), The indicated cells were treated with EGF for 1 min for determination of F-Actin induction
by flow cytometry. (E), Constitutive expression of GFP-RhoGDI-Re in XIAP
2/2(Si-RhoGDI) was verified by Western Blotting. (F and G), Relative
induction of F-Actin in the presence of EGF was determined by spectrophotometer (F), and levels of filamentous Actin were observed under confocal
microscopy (G) in the indicated transfectants. The asterisk (*) indicates a significant increase in comparison to those in XIAP
2/2(Si-Control) (p,0.05),
and the (§) indicates a significant decrease in comparison to those in XIAP
2/2(Si-RhoGDI) cells (p,0.001, n=3).
doi:10.1371/journal.pone.0035682.g006
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35682Figure 7. XIAP RING Domain was Responsible for RhoGDI Interaction Independent on its E3 Ligase Activity. (A), XIAP
2/2 cells were
transfected with GFP-RhoGDI, along with HA-XIAP, HA-XIAP H467A, HA-XIAP DRING, or HA-XIAP DBIR. Co-immunoprecipitation was performed with
anti-GFP antibody-conjugated agarose beads. Immunoprecipitates were then subjected to immunoblotting for detection of XIAP using HA antibody.
(B). WT(Vector), XIAP
2/2(Vector) and XIAP
2/2(HA-XIAP) HCT116 cells were transfected with constructs of GFP-RhoGDI in combination with Ubiquitin-
XIAP E3 Ligase and RhoGDI
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The specific cells were cultured in 10% FBS McCoy’s 5A
medium till 80–90% confluent. The medium was replaced with
0.1% FBS McCoy’s 5A medium and incubated for 4 h. Cells were
then treated with 25 ng/ml EGF for various time periods, fixed
with 3.7% formaldehyde for 10 min in PBS and permeabilized
with 0.1% Triton X-100 in PBS for 10 min. After washing with
PBS 3 times, cells were blocked in 1% BSA/PBS at room
temperature for 20 min, and then stained on a rotator with F-actin
specific dye, Oregon Green 488-phalloidin (1:40 in 1% BSA/PBS,
Invitrogen), for 30 min. Cells were washed with PBS again 3 times
and the bound phalloidin was extracted using 100% methanol at
4uC for 90 min. After extraction, methanol extraction was
collected, and plated cells were washed with PBS 3 times and
subjected to a BCA assay to determine total cell protein.
Fluorescence of methanol extraction solution for each sample
was recorded at 465 nm excitation and 535 nm emission by
spectrophotometer, and normalized against total protein in each
sample [38]. The results were expressed as relative F-actin content:
F-actin(Tn)/F-actin(T0)=[Fluorescence(Tn)/mg per ml]/[Fluores-
cence(T0)/mg per ml].
Quantification of F-actin content within cells was also
determined by flow cytometry according to Kobayahsi’s method
[43]. In brief, cells (3610
5) were seeded into each well of 6-well
plates and cultured in 10% FBS McCoy 5A medium until 90%
confluent. After stimulation with EGF for different periods of time,
cells were fixed with 3.7% formaldehyde for 10 min and
permeabilized with acetone for 5 min at 220uC. The cells were
then blocked in 1% BSA/PBS and stained with phalloidin (3 mg/
mL) for 30 min at 37uC, washed twice with PBS, re-suspended in
PBS and then analyzed by flow cytometry. Relative F-actin
content was expressed as an F-actin induction (averaged
fluorescence of tested cells at specified time/averaged fluorescence
of medium control cells).
Immunofluorescent Staining and Confocal Microscope
HCT116 and its transfectants were cultured on cover slides in
10% FBS McCoy’s 5A medium for 48 h. For EGF stimulation, the
medium was replaced with 0.1% FBS McCoy’s 5A medium and
incubated for 4 h and then treated with EGF (25 ng/ml) for the
times indicated. The cells were fixed with 3.7% paraformaldehyde
for 15 min and then permeabilized with 0.1% TritonX-100 in
PBS for 15 min at room temperature. The cells were then blocked
with 1% BSA/PBS for 30 min, and incubated with Oregon-
conjugated phalloidin for 30 min at room temperature, and then
stained with 0.1 mg/ml DAPI for 1 min. The slides were washed
three times with PBS and mounted with antifade reagent
(Molecular Probes). The cells were observed under a confocal
microscope (Leica DMI6000B). The fluorescence of cells was
quantified by the software of ImageJ (version 1.37; National
Institutes of Health).
Immunoprecipitation
Cells were lysed in cell lysis buffer (1% Triton X-100, 150 mM
NaCl, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA,
0.2 mM Na3VO4, 0.5% NP-40, and complete protein cocktail
inhibitors from Roche) on ice. Lysate (0.5 mg) was pre-cleared by
incubation with Protein A/G plus-agarose (Santa Cruz Biotech-
nology, Inc.) and then incubated with specific antibody at 4uC for
2 h–12 h. Protein A/G plus-agarose (40 ml) were added to the
mixture and incubated with agitation for an additional 4 h at 4uC.
The immunoprecipitate was washed three times with cell lysis
buffer and subjected to Western Blotting assay.
Western Blotting
Cell extracts were prepared with cell lysis buffer (10 mM Tris-
HCl, pH 7.4, 1% SDS, and 1 mM Na3VO4) and protein
concentrations were determined by the protein quantification
assay kit (Bio-Rad Laboratories, Hercules, CA). Thirty mgo f
proteins were resolved by SDS-PAGE, and subsequently probed
with the indicated primary antibodies and AP-conjugated
secondary antibody. Signals were detected by the enhanced
chemifluorescence system as described in our previous publica-
tions [23]. The results were representative of at least three
independent experiments. Antibodies against HA, XIAP (rabbit,
for Western Blotting), and GFP were purchased from Cell
Signaling Technology Inc (Boston, MA); against RhoGDI (Rabbit)
was from Millipore (Billerica, MA); against XIAP (mouse, for IP)
was from BD Science; against GADPH was obtained from Cell
Signaling Technology, Inc. (Boston) or Sungene Biotech (Tianjin,
China). Anti-GFP antibody-conjugated agarose beads were from
Vector Laboratories, Inc. (Burlingame, CA).
Statistical Methods
Student’s t-test was utilized for determining the significance of
differences. The differences will be considered significant at a
p#0.05.
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